LIPOSOMAL APPLICATIONS TO CANCER-THERAPY

被引:16
作者
NAMBA, Y [1 ]
OKU, N [1 ]
机构
[1] UNIV SHIZUOKA,DEPT RADIOBIOCHEM,YADA,SHIZUOKA 422,JAPAN
关键词
D O I
10.1177/088391159300800205
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:158 / 177
页数:20
相关论文
共 64 条
[1]   A MURINE OVARIAN TUMOR WITH UNIQUE METASTASIZING CAPACITY [J].
ALESSANDRI, G ;
GIAVAZZI, R ;
FALAUTANO, P ;
SPREAFICO, F ;
GARATTINI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) :651-&
[2]  
Allen T M, 1989, Proc West Pharmacol Soc, V32, P111
[3]   UPTAKE OF LIPOSOMES BY CULTURED MOUSE BONE-MARROW MACROPHAGES - INFLUENCE OF LIPOSOME COMPOSITION AND SIZE [J].
ALLEN, TM ;
AUSTIN, GA ;
CHONN, A ;
LIN, L ;
LEE, KC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1061 (01) :56-64
[4]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[5]   PHARMACOKINETICS AND METABOLISM OF MURAMYL DIPEPTIDE AND NOR-MURAMYL DIPEPTIDE [H-3-LABELED] IN THE MOUSE [J].
AMBLER, L ;
HUDSON, AM .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1984, 6 (02) :133-139
[6]  
ANDERSON PM, 1989, J IMMUNOL, V142, P1383
[7]  
ANDERSON PM, 1990, CANCER RES, V50, P1853
[8]  
ASHER A, 1987, J IMMUNOL, V138, P963
[9]   LIPOSOMES FOR THE SUSTAINED DRUG RELEASE INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1029 (01) :91-97
[10]  
BRODT P, 1989, CANCER IMMUNOL IMMUN, V28, P54